{"title": "Pangolin homology associated with 2019-nCoV", "body": "To explore potential intermediate host of a novel coronavirus is vital to rapidly control 2 continuous COVID-19 spread. We found genomic and evolutionary evidences of the 3 occurrence of 2019-nCoV-like coronavirus (named as Pangolin-CoV) from dead Malayan 4 Pangolins. Pangolin-CoV is 91.02% and 90.55% identical at the whole genome level to 5 2019-nCoV and BatCoV RaTG13, respectively. Pangolin-CoV is the lowest common 6 ancestor of 2019-nCoV and RaTG13. The S1 protein of Pangolin-CoV is much more 7 closely related to 2019-nCoV than RaTG13. Five key amino-acid residues involved in the 8 interaction with human ACE2 are completely consistent between Pangolin-CoV and 2019- 9 nCoV but four amino-acid mutations occur in RaTG13. It indicates Pangolin-CoV has 10 similar pathogenic potential to 2019-nCoV, and would be helpful to trace the origin and 11 probable intermediate host of 2019-nCoV. 12 . CC-BY-NC-ND 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi. org/10.1101 org/10. /2020 which is close on the outbreak of COVID-19. From their published results, all virus contigs 1 assembled from 2 lung samples (lung07, lung08) showed not high identities ranging from 2 80.24% to 88.93% with known SARS coronavirus. Hence, we conjectured that dead 3 Malayan pangolin may carry a new coronavirus close to 2019-nCoV. 4 To confirm our assumption, we downloaded raw RNA-seq data (SRA accession 5 number PRJNA573298) of those two lung samples from SRA and conducted consistent 6 quality control and contamination removing as described by Liu's study (7) . We found 1882 7 clean reads from lung08 sample mapped upon 2019-nCoV reference genome (GenBank 8 Accession MN908947)(3) with high genome coverage of 76.02%. We performed de novo 9 assembly of those reads and totally obtained 36 contigs with length ranging from 287bp to 10 2187bp with mean length of 700bp. Blasting against proteins from 2845 coronavirus 11 reference genomes including RaTG13, 2019-nCoVs and other known coronaviruses, we 12 found 22 contigs can be best matched to 2019-nCoVs (70.6%-100% aa identity; average: 13 95.41%) and 12 contigs matched to Bat SARS-like coronavirus (92.7%-100% aa identity; 14 average: 97.48%) (Table S1 ). These results indicate Malayan pangolin indeed carries a 15 novel coronavirus (here named as Pangolin-CoV) close to 2019-nCoV. 16 Using reference-guided scaffolding approach, we created Pangolin-CoV draft 17 genome (19,587 bp) based on the above 34 contigs. Remapping 1882 reads against the draft 18 genome resulted in 99.99% genome coverage at a mean depth of 7.71 X (range: 1X-47X) 19 ( Figure 1A) . Based on Simplot analysis, Pangolin-Cov showed highly overall genome 20 . CC-BY-NC-ND 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi. org/10.1101 org/10. /2020 sequence identity throughout the genomes to RaTG13 (90.55%) and 2019-nCoV (91.02%) 1 ( Figure 1B) , although there is greatly high identity 96.2% between 2019-nCoV and 2 RaTG13(3). Another SARS-like coronavirus more similar to Pangolin-Cov were Bat 3 SARSr-CoV ZXC21(85.65%) and Bat SARSr-CoV ZC45 (85.01%). These results indicate 4 Pangolin-Cov may be the common origin of 2019-nCoV and RaTG13. 5 The viral genome organization of Pangolin-Cov was characterized by sequence 6 alignment against 2019-nCoV (GenBank Accession MN908947) and RaTG13. The 7 Pangolin-Cov genome consists of six major open reading frames (ORFs) common to 8 coronaviruses and other four accessory genes ( Figure 1C and Table S2 ). Further analysis 9 indicates that Pangolin-Cov genes covered 2019-nCoV genes with coverage ranging from 10 45.8% to 100% (average coverage 76.9%). Pangolin-Cov genes shared high average 11 nucleotide and amino identity with both 2019-nCoV (MN908947) (93.2% nt/ 94.1% aa) 12 and RaTG13 (92.8% nt/93.5% aa) ( Figure 1C and Table S2) . Surprisingly, some of 13 Pangolin-Cov genes showed higher aa sequence identity to 2019-nCoV than RaTG13, 14 including orf1b (73.4/72.8), S-protein (97.5/95.4), orf7a (96.9/93.6), and orf10 (97.3/94.6).\n\nHigh S-protein amino acid identity implies function similarity between Pangolin-Cov and 16 2019-nCoV. 17 To determine the evolutionary relationships among Pangolin-Cov, 2019-nCoV and 18 previously identified coronaviruses, we estimated phylogenetic trees based on the 19 nucleotide sequences of the whole genome sequence, RNA-dependent RNA polymerase 20 . CC-BY-NC-ND 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the . https: //doi.org/10.1101 //doi.org/10. /2020 gene (RdRp), non-structural protein genes ORF1a and 1b, and the main structural proteins 1 encoded by the S and M genes. In all phylogenies, Pangolin-CoV, RaTG13 and 2019-nCoV 2 were clustered into a well-supported group, here named as \"SARS-CoV-2 group\" ( Figure   3 2 and Figures S1 to S2) . This group represents a novel Beta-coronaviruses group. Within 4 this group, RaTG13 and 2019-nCoV was grouped together, and the Pangolin-CoV was 5 their lowest common ancestor. However, whether the basal position of the SARS-CoV-2 6 group is SARSr-CoV ZXC21 and/or SARSr-CoV ZC45 or not is still in debate. Such 7 debate also occurred in both Wu et al.(3) and Zhou et al. (2) studies. Possible explanation 8 is due to a past history of recombination in Beta-CoV group(3). It is noteworthy that our 9 discovered evolutionary relationships of coronaviruses shown by the whole genome, RdRp 10 gene, and S-gene were highly consistent with that discovered by complete genome 11 information in Zhou et al. study(2) . It indicates our Pangolin-CoV draft genome has enough 12 genomic information to trace true evolutionary position of Pangolin-CoV in coronaviruses. 13 The coronavirus spike (S) protein consisting of 2 subunits (S1 and S2) mediates 14 infection of receptor-expressing host cells and is a critical target for antiviral neutralizing 15 antibodies. S1 contains a receptor binding domain (RBD) about 193 amino acid fragment, 16 which is responsible for recognizing and binding with the cell surface receptor (8, 9) . Zhou 17 et al. had experimentally confirmed that 2019-nCoV is able to use human, Chinese 18 horseshoe bats, civet, and pig ACE2 as an entry receptor in the ACE2-expressing cells(2), 19 suggesting the RBD of 2019-nCoV mediates infection to human and other animals. To gain 20 . CC-BY-NC-ND 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.02.19.950253 doi: bioRxiv preprint a sequence-level insight into understanding pathogen potential of Pangolin-Cov, we 1 investigated the amino acid variation pattern of S1 protein from Pangolin-CoV, 2019-2 nCoV, RaTG13, and other representative SARS-CoVs. The amino acid phylogenetic tree 3 showed the S1 protein of Pangolin-CoV is more closely related to that of 2019-CoV than 4 RaTG13. Within the RBD, we further found Pangolin-CoV and 2019-nCOV was highly 5 conserved with only one amino acid change (500H/500Q) (Figure 3) but not belonging to 6 five key residues involved in the interaction with human ACE2 (2, 9) . In contrast, RaTG13 7 has 17 amino acid residue changes and 4 of them belonged to key amino acid residue 8 (Figure 3) . These results indicate Pangolin-Cov has similar pathogen potential to 2019-9 nCoV. 10 The nucleocapsid protein (N-protein) is the most abundant protein in coronavirus.\n\nThe N-protein is a highly immunogenic phosphoprotein, and it is normally very conserved. 12 The N protein of coronavirus is often used as a marker in diagnostic assays. To gain a 13 further insight into the diagnostic potential for Pangolin-Cov, we investigated the amino The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10. 1101 RaTG13 and SARS-CoVs, which are mutated as 38S and 268A in 2019-nCoV. Only one 1 amino acid residue shared by Pangolin-CoV and other SARS-CoVs (129E) is consistently 2 changed in both 2019-nCoV and RaTG13 (129D). Our observed amino acid changes in N-3 protein would be useful for developing antigen for much more sensitive serological 4 detection of 2019-nCoV. 5 Based on published metagenomic data, this study provides the first report on a 6 potential closely related kin (Pangolin-CoV) of 2019-nCoV, which was discovered from 7 dead Malayan Pangolins after extensive rescue efforts. Aside from RaTG13, the Pangolin-8 CoV is the most closely related to 2019-nCoV. Due to original sample unavailable, we did 9 not perform further experiments to confirm our findings, including PCR validation, 10 serological detection, and even the isolation of virus particle etc. However, on 7 February, The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.02.19.950253 doi: bioRxiv preprint\n\nData preparation 2 We downloaded raw data of lung08 and lung07 published by Liu's study (7) Read Assembly and construction of consensus sequence 10 Virus-targeted reads were assembled de novo using MEGAHIT (v1.1.3)(12). Read 11 remapping to assembled contigs was performed by using Bowtie2(11). Mapping coverage 12 and depth were produced using Samtools (version 1.9)(13). Contigs were taxonomically 13 annotated using BLAST 2.9.0+ against 2845 Coronavirus reference genomes (Table S1) Phylogenetic relationship analysis 9 Sequence alignment was carried out using MUSCLE software(14). Alignment 10 accuracy was checked manually base-by-base. Gblocks (15) The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.02.19.950253 doi: bioRxiv preprint The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.02.19.950253 doi: bioRxiv preprint The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.02.19.950253 doi: bioRxiv preprint Table S2 .\n\nHuman CoV 229E 93\n\nBat SARSr-CoV YNLF31C Beta-CoV/Wuhan-Hu-1\n\nBat Hp-BetaCoV Zhejiang2013 -02 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 432 Beta-CoV/Wuhan/ IPBCAMS-WH-05 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 432 Beta-CoV/Wuhan/ IPBCAMS-WH-03 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 432 Beta-CoV/Wuhan/IPBCAMS- WH-04 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . -01 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 522 Beta-CoV/Wuhan/IPBCAMS- WH-04 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 522 Beta-CoV/Wuhan/IPBCAMS- WH-01 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|   MSDNGPQ-NQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAAL  .......-....................................................................................................................................................................................................................  .......-....................................................................................................................................................................................................................  .......-....................................................................................................................................................................................................................  .......-....................................................................................................................................................................................................................  .......-....................................................................................................................................................................................................................  .......-.............................P.................................................................................................................................................................................S....  .......-................A............P...........................R..............................................................E......N.............................................................T......................  .......-..SS............SDNS.....N...P.........................N.T..............K......................E........................E........................................................................................T..  .......-...S............SDNSK....N...P.........................N.T..............K......................E........................E........................................................................................T..  .......S...S.........T...DN....G.N...P.........................E.R.............G..............V........E................S.......E..V....................N....T..................................GN...........N......SG..ET..  .......S...S.........T...DN....G.N...P.........................E.R.............G..............V........E................S.......E..V....................N....T..................................GN...........N......SG..ET..  .......S...S.........T...DN....G.N...P.........................E.R.............G..............V........E................S.......E..V....................N....T..................................GN...........N......SG..ET..  .......P...S.........T.P.DN....G.N...P.........................E.R.............G..............V........E................S.......E..V....................N....T..................................GN...........N......SG..ET..  .......P...S.........T..IDN....G.N...P.........................E.R.............G..............V........E................S.......E..V....................N....T..................................GN...........N......SG..ET..  ......H-...S.S.......T...DN....G.N...P.........................E.R..Q..........G..............V........E................S.......E.......................N....T..................................GN................I.SG..ET..  .......P...S.........T...DN....G.N...P.........................E.R.............G..............V........E................S.......E.......................N....T..................................GN...........N......SG..ET..  .......-S..S.........T..ADN..D.G.....P.........................E.R.............GK........K....V........E................S.......E..V....................N.......................................GN...........N ...........V................................Q......................D...........................................H..........Q...N..........................T..A.P........P.........M....R...N...GA.......*  ..............V.....................R..........Q......................D...........................................H..........Q...N..........................T..A.P........P.........M....R...N...GA.......*  ..............V................................Q......................D...........................................H..........Q...N..........................T..A.P........P.........M....R...N...GA.......*  ..............V................................Q......................D...........................................H..........Q...N..........................T..A.P........P.........M....R...N...GA.......*  ..............V................................Q............D.........D...........................................H..........Q...N..........................T..A.P........P.........M....R...N...GA.......*  ..............V................................Q......................D...........................................H..........Q...N..........................T..A.P........P.........M....R...N...GA.......*  ..............V.......P........................Q..................................................................H..........Q...N..........................T..A.P....P...P.........M....R...N...GA.......*  ..............V.......P........................Q............................I.....................................H..........Q...N..........................T..A.P........P.........M....R...H...GA.......*  ..............V................................Q......................D.T.........................................H..........Q...N..........................T..A.P........P.........M....R...N...GA.......*  ..............V................TS..............Q............D........................................S..........I.H..........Q...N..........................T..A.P........P.........M....R...N...GA.......*  ..............V.................S..............Q............D.....................................................H..........Q...N..........................T..A.P........P.........M....R...N...GA.......*  ..............V................................S..................................................................H..........Q...N..........................T..A.P....-...P.........M....R...N...GA.......*  ..............V..RS............................Q..................................................................H..........Q...N............I.............T..A.P........P.........M....R...N...GA.......*  ..............V................................Q..................................................................H..........Q...N.M..........A.............T..A.P Beta-CoV/Wuhan-Hu-1\n\nBeta-CoV/Wuhan/IPBCAMS-WH-03\n\nBat Hp-BetaCoV Zhejiang2013\n\nRousettus bat CoV HKU9 \n\nBat SARSr-CoV WIV16\n\nBat SARSr-CoV Rs4231\n\nBat SARSr-CoV SHC014\n\nBat SARSr-CoV YNLF31C\n\nBat SARSr-CoV GX2013\n\nBat SARSr-CoV Rp3\n\nBat SARSr-CoV SC2018\n\nBat SARSr-CoV HuB2013\n\nBat SARSr-CoV Rf1\n\nBat SARSr-CoV SX2013\n\nBat SARSr-CoV HKU3-1\n\nBat SARSr-CoV Longquan-140\n\nBat SARSr-CoV ZC45\n\nBat CoV RaTG13\n\nBeta-CoV/Wuhan-Hu-1\n\nBeta-CoV/Wuhan/IPBCAMS-WH-01 0.20\n\nBat SARSr-CoV WIV16\n\nBat SARSr-CoV Rs4231\n\nBat SARSr-CoV SHC014\n\nBat SARSr-CoV GX2013\n\nBat SARSr-CoV Rp3\n\nBat SARSr-CoV YNLF31C\n\nBat SARSr-CoV SC2018\n\nBat SARSr-CoV HuB2013\n\nBat SARSr-CoV Rf1\n\nBat SARSr-CoV SX2013\n\nBat SARSr-CoV HKU3-1\n\nBat SARSr-CoV Longquan-140\n\nBat SARSr-CoV BM48-31\n\nBat SARSr-CoV ZC45\n\nBat CoV RaTG13\n\nBeta-CoV/Wuhan-Hu-1\n\nBeta-CoV/Wuhan/IPBCAMS-WH-03\n\nBat Hp-BetaCoV Zhejiang2013\n\nRousettus bat CoV HKU9 \n\nBat SARSr-CoV WIV16\n\nBat SARSr-CoV Rs4231\n\nBat SARSr-CoV SHC014\n\nBat SARSr-CoV GX2013\n\nBat SARSr-CoV Rp3\n\nBat SARSr-CoV YNLF31C\n\nBat SARSr-CoV SC2018\n\nBat SARSr-CoV Rf1\n\nBat SARSr-CoV SX2013\n\nBat SARSr-CoV HuB2013\n\nBat SARSr-CoV HKU3-1\n\nBat SARSr-CoV Longquan-140\n\nBat SARSr-CoV ZXC21\n\nBat SARSr-CoV BM48-31\n\nBeta-CoV/Wuhan-Hu-1\n\nBeta-CoV/Wuhan/IPBCAMS-WH-03\n\nBat Hp-BetaCoV Zhejiang2013\n\nRousettus bat CoV HKU9 "}